Skip to contentC
cbdMD, Inc.
C
YCBDcbdMD, Inc. Q3 2020 · 10-Q
Revenue$10.64M$10.64M+32.9% vs Q3 2019 Net Income-$8.95M-$8.95MN/M vs Q3 2019 EPS Diluted$0.00$0.00— vs Q3 2019 Gross Profit$6,888,521+35.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
cbdMD, Inc. · CIK 1644903 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,130,029N/M Free Cash Flowderived-$1,185,429N/M Margins · derivedGross margin64.8%+1.2 pt vs Q3 2019
Operating margin-12.6%+365.8 pt vs Q3 2019
Net margin-84.2%+280.6 pt vs Q3 2019
ended Jun 30, 2020 · filed Aug 12, 2020 · 43 d after period end